Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Nestlé Faces Potential Losses Due to Global Infant Formula Recall
Nestlé’s recent global recall of infant formula products has the potential to cost the company up to SFr1.2bn in lost sales and could pose a threat to its brand reputation. This setback comes at a crucial time for new chief executive Philipp Navratil as he works towards rebuilding investor trust in the Swiss food giant.
The recall, which was initiated on Monday, includes various batches of infant formula brands such as NAN, BEBA, Guigoz, SMA, and Alfamino, due to a possible contamination with cereulide, a toxin known to cause nausea and vomiting. Initially issued in Europe, the recalls have since spread to regions such as Asia, Latin America, the Middle East, and Africa, impacting a total of 46 countries.
Analysts at Jefferies have estimated that around 1.3 per cent of Nestlé’s group sales could be affected, translating to a potential exposure of SFr1.2bn. Similarly, Warren Ackerman from Barclays has also calculated a similar risk level, projecting the total impact to range between 0.8 and 1.5 per cent of group sales. As a result, Nestlé’s shares have already seen a 4.6 per cent decline this year.
For Navratil, who took on the CEO role in September following the dismissal of former chief executive Laurent Freixe, this recall presents a significant challenge at the start of his tenure. The company is currently focused on driving growth and reducing debt, with plans to cut 16,000 jobs over the next two years.
The potential reputational damage from the infant formula recall is a primary concern for analysts, especially in light of previous operational issues and governance controversies that have plagued Nestlé. Recent incidents, including a product recall in the US and a regulatory investigation in France, have already raised questions about the company’s credibility.
Jean-Philippe Bertschy, an analyst at Vontobel, emphasized that the reputational risk far outweighs the financial impact of the recall. He noted that Nestlé’s handling of the situation could have lasting implications on consumer perception and investor confidence.
While Nestlé has stated that the recall represents less than 0.5 per cent of annual sales and anticipates minimal financial repercussions, concerns remain about the company’s communication and crisis management strategies. The Swiss group attributed the issue to a quality problem with arachidonic acid oil, an ingredient in the formula, but assured that no illnesses have been linked to the affected products thus far.
Going forward, consumer response to the recalls will vary by market, as seen in previous cases such as Danone’s recall in China in 2013 and Abbott’s recall in the US in 2022. How Nestlé navigates this challenging period will be crucial in determining its reputation and future success in the global market.
